Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Combinations of sEH inhibition and PPARγ activation have beneficial effects on cardiometabolic syndrome

Combinations of sEH inhibition and PPARγ activation have beneficial effects on cardiometabolic syndrome

Transplant, MCS physicians examine value of hTEE management at symposium in Montreal

Transplant, MCS physicians examine value of hTEE management at symposium in Montreal

Omega-3 polyunsaturated fatty acids associated with lower risk of heart failure mortality in adults

Omega-3 polyunsaturated fatty acids associated with lower risk of heart failure mortality in adults

American Heart Association: Direct, indirect costs to treat heart failure could more than double in 2030

American Heart Association: Direct, indirect costs to treat heart failure could more than double in 2030

Phase 1 clinical study of rHIgM22 initiated for treatment of multiple sclerosis

Phase 1 clinical study of rHIgM22 initiated for treatment of multiple sclerosis

Unavoidable damage to heart and lungs can be limited by using CVD drug

Unavoidable damage to heart and lungs can be limited by using CVD drug

Highly active ART does not appear to impair heart function, study suggests

Highly active ART does not appear to impair heart function, study suggests

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

Study: Shock wave-facilitated cell therapy improves outcomes in patients with chronic heart failure

Study: Shock wave-facilitated cell therapy improves outcomes in patients with chronic heart failure

Reducing preventable hospital readmissions may take longer, say researchers

Reducing preventable hospital readmissions may take longer, say researchers

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

Loyola University Medical Center physicians deploy aortic valve through patient's abdomen

Loyola University Medical Center physicians deploy aortic valve through patient's abdomen

EKG could predict cardiovascular illness

EKG could predict cardiovascular illness

UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Large numbers of ER visits go unreported in calculating hospital readmission rates

Large numbers of ER visits go unreported in calculating hospital readmission rates

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Michigan's first cardio-oncology clinic launched to prevent heart problems

Michigan's first cardio-oncology clinic launched to prevent heart problems

L-carnitine improves cardiac health in patients after heart attack, say researchers

L-carnitine improves cardiac health in patients after heart attack, say researchers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.